LAUSR

Corticosteroids are widely prescribed in dermatology department and a rational prescribing lead to maximum benefit and minimum untoward effects. The objectives of this study were to assess the corticosteroid prescribing pattern for various skin diseases and to identify, monitor and assess any drug interactions and adverse reactions if any associated with their use. A prospective cross-sectional study on corticosteroid utilization pattern in dermatology department of a tertiary care teaching hospital was done by reviewing 205 inpatient cases for a period of 6 months. The data was collected with respect to demographics, medical and medication history, laboratory data and drugs prescribed during hospitalization and at discharge. A descriptive statistical analysis was performed to report the findings in terms of number and percentage. Corticosteroids were prescribed in 129 cases with 72male patients most in 51-60-year age group and 57female patients with 28% in 31-40-year age group. The common indications were psoriasis, dermatitis, and pemphigus. Prednisolone (27.4%) followed by clobetasol (22.04%) were most commonly prescribed. 48.6% therapy was by topical route, 28.2% by oral and 23.03% parenteral route. At discharge prednisolone and clobetasol were mostly prescribed and topical route was the most preferred route. Drug interactions involving drugs like betamethasone, triamcinolone, dexamethasone, and prednisolone were observed but no adverse reactions were reported. With a wide choice of corticosteroids and dosage forms available to treat dermatological conditions the rational therapy should consider the appropriate choice of drugs, potency, effectiveness and the cost.